4/A//SEC Filing
Talecris Biotherapeutics Holdings Corp. 4/A
Accession 0001260616-10-000001
CIK 0001405197operating
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 1:10 PM ET
Size
6.0 KB
Accession
0001260616-10-000001
Insider Transaction Report
Form 4/AAmended
LYNCH THOMAS J
Sr. VP, Corp. Compliance
Transactions
- Sale
Common Stock
2010-09-03$22.50/sh−131,929$2,968,403→ 2,631 total
Footnotes (3)
- [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2010.
- [F2]The Reporting Person is amending the Form 4 filed on September 7, 2010 with respect to the September 3, 2010 disposition transaction reported in that Form 4, to correctly report that the number of shares disposed of was 131,929 shares instead of 113,440 shares.
- [F3]The number of shares reported consists of restricted share units representing the right to receive 2,631 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.
Documents
Issuer
Talecris Biotherapeutics Holdings Corp.
CIK 0001405197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001405197
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 1:10 PM ET
- Size
- 6.0 KB